ANNA-MARIE SIMS: Open Payments
NPI 1518418136 · LOMA LINDA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$619 in 32 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $655 · 2025 $619
Food & beverage: $619
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 7 | $170 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $118 |
| SCPHARMACEUTICALS INC. | 4 | $63 |
| Lilly USA, LLC | 3 | $56 |
| Amgen Inc. | 3 | $49 |
| E.R. Squibb & Sons, L.L.C. | 2 | $32 |
| Alnylam Pharmaceuticals Inc. | 2 | $29 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
| Baxter Healthcare | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
Products named: JARDIANCE, ELIQUIS, VYNDAQEL, FUROSCIX, REPATHA, MOUNJARO, ONPATTRO, WAINUA.
Industry payments across CA — which companies pay providers there.
